Bristol-Myers Squibb
BMY
#173
Rank
HK$1.005 T
Marketcap
HK$492.04
Share price
2.17%
Change (1 day)
48.63%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): HK$35.50

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is HK$35.62. In 2025 the company made an earnings per share (EPS) of HK$27.14 an increase over its 2024 EPS that were of -HK$34.68.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$35.5030.79%
2025HK$27.14-178.28%
2024-HK$34.68-213.92%
2023HK$30.4430.2%
2022HK$23.38-6.04%
2021HK$24.88-179.29%
2020-HK$31.38-281.37%
2019HK$17.30-27.21%
2018HK$23.77
2016HK$20.95175.26%
2015HK$7.61-19.83%
2014HK$9.49-22.44%
2013HK$12.2434.48%
2012HK$9.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.52 92.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$52.25 46.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-83.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$28.01-21.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$234.44 558.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$127.25 257.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$14.93-58.09%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$44.56 25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$9.93-72.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$52.40 47.14%๐Ÿ‡ฌ๐Ÿ‡ง UK